Deadline: 7 August 2025 HSE has received applications for authorisation for the following substances/uses: -
Reference: AFA067-01 Applicant: Abbott Laboratories Limited
Application type: Review Report  Â
Substance: 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated
Use: Professional use as a surfactant in the final use of In-Vitro Diagnostic Devices (IVDs) for clinical testing using ARCHITECT, Alinity and ABBOTT PRISM automated analyser systems
View the consultation: Applications for authorisation AFA067-01
-
Reference: AFA068-01 Applicant: ACF Howell
Application type: Initial
Substance: Chromium trioxide
Use: Functional chrome plating with decorative character
View the consultation: Applications for authorisation AFA068-01
Article 64 in the UK REACH Regulation makes provisions for HSE to obtain and use additional information on possible alternatives or technologies as part of the opinion forming process. Any third parties with an interest in the application are strongly encouraged to share any relevant information. Scientific and technical information on possible alternatives or technologies should be submitted directly to HSE using the commenting webform and templates by 7 August 2025. Non-confidential information will be published on HSEâs website. Visit HSE's website for details of the adopted opinions, granted UK REACH authorisations and in-progress applications. PFAS are a broad class of synthetic, fluorinated organic chemicals. They can remain in the environment for decades and can move easily through soil, water and air once in the environment. There is also a growing concern about human health risks associated with longer-term exposure to PFAS. View the statement on GOV.UK: Interim position statement on the approach to PMT concept to support UK REACH risk management of PFAS If you have any questions relating to this ebulletin, please contact us. | 
